Trending...
- Fort Lauderdale Dentist Dr. Taskonak & IN A DAY SMILE Receive Emmy Nomination for Life-Changing Documentary "The Weight of a Smile"
- Curry Leaves Indian Cuisine Celebrates Grand Opening at Westshore Plaza -As Seen on Good Life Tampa
- CCHR: New Data Shows Millions of U.S. Children Caught in Escalating Psychiatric Polypharmacy
Our latest case study follows Jack Taxis, an EMS Coordinator at Rush Copley Medical Center, and how he has enhanced EMS communication, improved treatment times, and advanced his team's operational efficiency over the span of his 37 year career.
RIDGEFIELD PARK, N.J. - CuisineWire -- General Devices (GD) has released a new case study detailing how Rush Copley Medical Center in Aurora, Illinois, has enhanced emergency care through GD's CAREpoint 3 Workstation. Over 37 years, Rush Copley's EMS communication systems have evolved from basic radio channels to cutting-edge solutions, significantly improving patient outcomes and care team efficiency.
Under the leadership of EMS Coordinator Jack Taxis, the adoption of GD's CAREpoint 3 has led to:
About the adoption of CAREpoint 3, Jack said "Buy in has been great. It has been phenomenal. I don't care if it's your personal life or professional like, if you don't have the c word meaning communication, you fall apart, you have to let people know what's going on"
More on Cuisine Wire
This case study demonstrates how a strong leader like Jack and modern healthcare communication tools can transform emergency care.
Download the Full Case Study Here.
Learn more about CAREpoint and the rest of the GD Solution Suite by watching our video https://youtu.be/U7fH6QiwA2c?si=vMxR0FYflp1Fv4IW
About GD [General Devices]
GD is a Healthtech company specializing in communication solutions that help EMS and hospitals deliver simply seamless patient care. Powered by responsive innovation, GD's user-friendly solutions facilitate rapid, secure, voice, telehealth and data sharing communications across care teams to help save time, money and lives. Backed by a 40+ year history and thousands of implementations, GD is an experienced industry leader. Visit https://general-devices.com/ to learn more.
Under the leadership of EMS Coordinator Jack Taxis, the adoption of GD's CAREpoint 3 has led to:
- STEMI response improvements
- Faster stroke care
- Enhanced trauma response
- Operational efficiency
- Exceptional support and service
- and more!
About the adoption of CAREpoint 3, Jack said "Buy in has been great. It has been phenomenal. I don't care if it's your personal life or professional like, if you don't have the c word meaning communication, you fall apart, you have to let people know what's going on"
More on Cuisine Wire
- 6 Holiday Looks That Scream "Old Money" But Cost Less Than Your Christmas Tree
- From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
- Deli Star Elevates Leadership and Advances Fresh Sous Vide Technology with Dr. Mark Atkinson
- Controversial Vegan Turns Rapper Launches First Song, "Psychopathic Tendencies."
- Inside the Fight for Affordable Housing: Avery Headley Joins Terran Lamp for a Candid Bronx Leadership Conversation
This case study demonstrates how a strong leader like Jack and modern healthcare communication tools can transform emergency care.
Download the Full Case Study Here.
Learn more about CAREpoint and the rest of the GD Solution Suite by watching our video https://youtu.be/U7fH6QiwA2c?si=vMxR0FYflp1Fv4IW
About GD [General Devices]
GD is a Healthtech company specializing in communication solutions that help EMS and hospitals deliver simply seamless patient care. Powered by responsive innovation, GD's user-friendly solutions facilitate rapid, secure, voice, telehealth and data sharing communications across care teams to help save time, money and lives. Backed by a 40+ year history and thousands of implementations, GD is an experienced industry leader. Visit https://general-devices.com/ to learn more.
Source: General Devices
0 Comments
Latest on Cuisine Wire
- New YouTube Channel Pair Launches to Bring Entertainment Nostalgia Back to Life
- BRAG Hosts Holiday Benefit — Awards 10 Student Scholarships & Honors Timberland with the Corporate Impact Award
- Orim Link Inc. Announces Official Launch, Bringing Modern Business Technology Solutions to Charlotte
- FittingPros Launches Industry's First Data-Driven Golf Club Fitting Directory
- Steady Café & Comedy Debuts as First Diabetic-Friendly Café Chain with Investor Openings
- Take Control of Your Color Matching with Boston Industrial Solutions' Newly Expanded Natron® UVPX Series Ink Colors
- "Dr. Vincent Michael Malfitano Expands Monterey–Sicily Cultural Diplomacy With Major International Media Engagement"
- Kaufman Development Breaks Ground on Detroit Micro Data Center, Expanding Its National AI Platform
- Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
- $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
- High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
- Top10Christmas.co.uk Releases the UK Christmas Toy Trends 2025 Report
- Talagat Business Academy Announces Joint Certificate Program With The University of Chicago Booth School of Business
- LocaXion and Asseco CEIT Announce First-to-Market RTLS-Driven Digital Twin Platform for Healthcare, Manufacturing, and Logistics
- Slotozilla Launches New Report on How AI Is Reshaping Careers and Society
- OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets
- Explosive Growth in U.S. Cryptocurrency Cloud Mining Sets The Stage for New Platform Launch with Daily Rewards in a Transparent Revenue-Share Model
- Qtex Cierra Ronda de $7 Millones para Estandarizar la Banca Transfronteriza en los Mercados Emergentes de Latinoamérica
- America's Most Festive Garages Wanted for Garage.com's 2025 Holiday Contest
- FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough


